Effect of emulsifier blend on the characteristics of sustained release diclofenac microspheres

被引:34
作者
Lewis, L [1 ]
Boni, R [1 ]
Adeyeye, CM [1 ]
机构
[1] Duquesne Univ, Grad Sch Pharmaceut Sci, Pittsburgh, PA 15282 USA
关键词
microsphere; diclofenac; sustained drug release; emulsifier;
D O I
10.3109/02652049809006858
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
This investigation involved the evaluation of the emulsifier blend effect on the development of sustained release diclofenac microspheres intended for use in a suspension formulation. The microspheres were prepared using the hydrophobic congealable disperse phase method. The emulsifier blend consisted of glycerol, monostearate (GMS), a hydrophobic emulsifier with HLB = 3.8, and Tween 80, a hydrophilic emulsifier with a HLB value of 15. The effect of this blend on the encapsulation efficiency, size distribution and drug release from the microspheres was studied. A critical amount of GMS (> 0.2 g) was found to be necessary for good encapsulation efficiency. X-ray diffractograms revealed that the drug retains its crystalline state within the microspheres, indicating that the drug is present as a dispersion within the wax matrix. Increasing amounts of Tween 80 caused an increase in the drug release while increased amounts of GMS retarded the release. The hydrophilic emulsifier and the emulsifier blend influenced the size distribution of the formed microspheres. With an increase in the amount of hydrophilic emulsifier, there was an initial increase in the percent of desired size fraction (137.5 mu m) of microspheres followed by a decrease. Microspheres with a larger size released the drug slowly compared to smaller size microspheres, while increase in drug load increased the rate of drug release. The release pattern fitted the Higuchi dissolution kinetics for spherical matrices. Different impeller blade designs formed microspheres that exhibited different release rates. The microspheres (mean size 137.5 mu m), had a release profile that made them suitable to be formulated as a sustained release suspension.
引用
收藏
页码:283 / 298
页数:16
相关论文
共 11 条
[1]  
ACKIGOZ M, 1995, PHARMAZIE, V50, P275
[2]   DEVELOPMENT AND EVALUATION OF SUSTAINED-RELEASE IBUPROFEN-WAX MICROSPHERES .1. EFFECT OF FORMULATION VARIABLES ON PHYSICAL CHARACTERISTICS [J].
ADEYEYE, CM ;
PRICE, JC .
PHARMACEUTICAL RESEARCH, 1991, 8 (11) :1377-1383
[3]  
ADEYEYE CM, 1994, PHARMACEUT RES, V4, P577
[4]   PSEUDOEPHEDRINE HCL MICROSPHERES FORMULATED INTO AN ORAL SUSPENSION DOSAGE FORM [J].
BODMEIER, R ;
CHEN, H ;
TYLE, P ;
JAROSZ, P .
JOURNAL OF CONTROLLED RELEASE, 1991, 15 (01) :65-77
[5]  
RANI KNS, 1993, INDIAN J PHARM SCI, V56, P45
[6]   USE OF SPARINGLY SOLUBLE SALTS TO PREPARE ORAL SUSTAINED-RELEASE SUSPENSIONS [J].
SHAH, KP ;
CHAFETZ, L .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 109 (03) :271-281
[7]  
TORRES D, 1992, MICROENCAPSULATION D, P17
[8]  
VILIVALAM VD, 1994, J MICROENCAPSUL, V4, P455
[9]   SURFACTANT EFFECTS ON ALGINATE MICROSPHERES [J].
WAN, LSC ;
HENG, PWS ;
CHAN, LW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 103 (03) :267-275
[10]   INFLUENCE OF HYDROPHILE-LIPOPHILE BALANCE ON ALGINATE MICROSPHERES [J].
WAN, LSC ;
HENG, PWS ;
CHAN, LW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 95 (1-3) :77-83